Combination therapy with gemcitabine in non-small cell lung cancer
- 31 January 1997
- journal article
- review article
- Published by Elsevier in European Journal Of Cancer
- Vol. 33, S14-S17
- https://doi.org/10.1016/s0959-8049(96)00326-7
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- 1080 Phase I trial of gemcitabine (GEM) and cisplatin (CP) for non-small cell lung cancer (NSCLC)European Journal Of Cancer, 1995
- 1086 A phase II study of gemcitabine with cisplatin in patients with non-small cell lung cancerEuropean Journal Of Cancer, 1995
- 1079 Gemcitabine plus cisplatin in non-small cell lung cancer: A phase II studyEuropean Journal Of Cancer, 1995
- Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trialsBMJ, 1995
- 2′,2′-Difluoro-deoxycytidine (gemcitabine) incorporation into RNA and DNA of tumour cell linesBiochemical Pharmacology, 1993
- Studies on the mechanism of the synergistic interaction between 2?-deoxy-5-azacytidine and cisplatinCancer Chemotherapy and Pharmacology, 1992